Needle and syringe

DEVICE3 trials

Sponsors

PharmaJet, Inc., PATH, Medical Research Council Unit, The Gambia

Conditions

Influenza ProphylaxisPoliomyelitisTuberculosis

Phase 4

Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe

CompletedNCT01644149

PharmaJet, Inc.Influenza Prophylaxis

Start: 2012-01-31End: 2012-02-29Updated: 2019-06-20

Unknown Phase

Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe

CompletedNCT01742364

PATHTuberculosis

Start: 2012-12-31End: 2013-12-31Updated: 2017-02-08

A Campaign-based ID fIPV Administration Trial

CompletedNCT02967783

Medical Research Council Unit, The GambiaPoliomyelitis

Start: 2017-02-07End: 2018-09-18Updated: 2019-01-03

Related Papers

Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.

2021-12-2115 citations